Φορτώνει......
Methodological approach to determine minor, considerable, and major treatment effects in the early benefit assessment of new drugs
At the beginning of 2011, the early benefit assessment of new drugs was introduced in Germany with the Act on the Reform of the Market for Medicinal Products (AMNOG). The Federal Joint Committee (G‐BA) generally commissions the Institute for Quality and Efficiency in Health Care (IQWiG) with this ty...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Biom J |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley and Sons Inc.
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5034755/ https://ncbi.nlm.nih.gov/pubmed/26134089 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/bimj.201300274 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|